https://www.taxtmi.com/caselaws?id=342588 Oxytetracycline Capsules I.P. 500 mg, being a generic medicine name in the Indian Pharmacopoeia, remained classifiable as a medicament other than a patent or proprietary medicament under Chapter heading 3003.20. The Pfizer logo was treated only as a house mark and did not convert the product into a patent or proprietary medicament under Chapter heading 3003.10. Reliance on the logo at the appellate stage also introduced a new basis not arising from the show cause notice or the adjudication order, which could not be sustained. The demand, penalty, and consequential findings were set aside. en-us Mon, 24 Apr 2017 00:00:00 +0530 Tue, 23 May 2017 10:25:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=342588 Oxytetracycline Capsules I.P. 500 mg, being a generic medicine name in the Indian Pharmacopoeia, remained classifiable as a medicament other than a patent or proprietary medicament under Chapter heading 3003.20. The Pfizer logo was treated only as a house mark and did not convert the product into a patent or proprietary medicament under Chapter heading 3003.10. Reliance on the logo at the appellate stage also introduced a new basis not arising from the show cause notice or the adjudication order, which could not be sustained. The demand, penalty, and consequential findings were set aside. Case-Laws Central Excise Mon, 24 Apr 2017 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=342588